Author Correction: Specific oncogene activation of the cell of origin in mucosal melanoma
Source: Nature.com· Swathy Babu, Jiajia Chen, Chloé S. Baron, Kaiwen Sun, Emily Robitschek, Alicia M. McConnell, Constance Wu, Aikaterini Dedeilia, Moshe Sade-Feldman, Rodsy Modhurima, Michael P. Manos, Kevin Y. Chen, Anna M. Cox, Calvin G. Ludwig, Manolis Kellis, Elizabeth I. Buchbinder, Nir Hacohen, Jiekun Yang, Genevieve M. Boland, Brian J. Abraham, David Liu, Leonard I. Zon, Megan L. Insco· August 20, 2026
SynaBot summary
Researchers have corrected a scientific paper concerning oncogene activation in mucosal melanoma. This correction clarifies the specific cellular origins and genetic triggers involved in the development of this rare cancer.
Key takeaways
- Correction clarifies oncogene's role in melanoma origin
- Research focuses on specific cell types and genetic activation
- Improves understanding of rare cancer development pathways
Why it matters
Understanding the precise genetic drivers of rare diseases like mucosal melanoma is crucial for developing targeted AI-driven diagnostic tools. This research refinement aids in building more accurate predictive models for cancer subtypes.
This story was reported by Nature.com. Read the full original article:
Read on Nature.com Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Tools
- Author of poemsAuthor of poems is an AI tool for individuals and teams that generates poetry tailored to unique visions, instantly supporting creative writing workflows.
- Co-AuthorCo-Author helps researchers write and refine their academic papers. It offers suggestions for phrasing, structure, and grammar, improving writing quality and efficiency for scientific communication.
